Insulet Corp. (PODD)
145.63
-2.53
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
-0.13
(-0.09%)
After-Hours: 20:00
Insulet Price to Book Value : 7.101 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 7.225 |
| August 20, 2026 | 7.162 |
| August 19, 2026 | 7.388 |
| August 18, 2026 | 7.218 |
| August 17, 2026 | 6.812 |
| August 14, 2026 | 6.990 |
| August 13, 2026 | 7.141 |
| August 12, 2026 | 7.074 |
| August 11, 2026 | 7.056 |
| August 10, 2026 | 6.966 |
| August 07, 2026 | 6.884 |
| August 06, 2026 | 6.793 |
| August 05, 2026 | 6.498 |
| August 04, 2026 | 8.135 |
| August 03, 2026 | 8.275 |
| July 31, 2026 | 8.063 |
| July 30, 2026 | 8.079 |
| July 29, 2026 | 8.32 |
| July 28, 2026 | 8.166 |
| July 27, 2026 | 8.046 |
| July 24, 2026 | 7.961 |
| July 23, 2026 | 7.723 |
| July 22, 2026 | 7.750 |
| July 21, 2026 | 7.984 |
| July 20, 2026 | 8.162 |
| Date | Value |
|---|---|
| July 17, 2026 | 8.000 |
| July 16, 2026 | 8.018 |
| July 15, 2026 | 7.767 |
| July 14, 2026 | 7.759 |
| July 13, 2026 | 7.903 |
| July 10, 2026 | 7.864 |
| July 09, 2026 | 7.719 |
| July 08, 2026 | 7.678 |
| July 07, 2026 | 7.878 |
| July 06, 2026 | 7.791 |
| July 02, 2026 | 8.021 |
| July 01, 2026 | 7.792 |
| June 30, 2026 | 7.424 |
| June 29, 2026 | 8.388 |
| June 26, 2026 | 8.415 |
| June 25, 2026 | 8.179 |
| June 24, 2026 | 7.916 |
| June 23, 2026 | 7.652 |
| June 22, 2026 | 7.390 |
| June 18, 2026 | 7.751 |
| June 17, 2026 | 7.632 |
| June 16, 2026 | 7.853 |
| June 15, 2026 | 7.877 |
| June 12, 2026 | 7.960 |
| June 11, 2026 | 7.933 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Abbott Laboratories | 3.950 |
| DexCom, Inc. | 13.11 |
| Boston Scientific Corp. | 2.844 |
| PROCEPT BioRobotics Corp. | 3.576 |
| Globus Medical, Inc. | 2.368 |
Price to Book Value Related Metrics
| PE Ratio | 28.87 |
| PS Ratio | 3.350 |
| PEG Ratio | 0.5396 |
| Price to Free Cash Flow | 38.49 |
| Price | 145.63 |
| Earnings Yield | 3.46% |
| Market Cap | 10.10B |
| PEGY Ratio | 0.5396 |
| Operating PE Ratio | 19.85 |
| Normalized PE Ratio | 29.40 |